FdaApplication
ANDA 215947
Identifiers
- fda_app_no: ANDA215947
Properties
| Property | Value |
|---|---|
| applicant_name | NOVUGEN ONCOLOGY SDN BHD |
| application_type | ANDA |
| approval_date | 2022-01-05 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| ABIRATERONE ACETATE | ABIRATERONE ACETATE | 500MG | TABLET;ORAL |
| ABIRATERONE ACETATE | ABIRATERONE ACETATE | 250MG | TABLET;ORAL |
2 products